Complications Associated with Intraperitoneal Chemotherapy Catheters
Authors:
- M. LeitaoMLM. Leitao
- P. SabbatiniPSP. Sabbatini
- N. BellinNBN. Bellin
- L. AlmadronesLAL. Almadrones
- L. LeonLLL. Leon
- D.R. SpriggsDSD.R. Spriggs
- R. BarakatRBR. Barakat
- 1 April 2001
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 81 (1) , 77-81
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year ResultsJNCI: Journal of the National Cancer Institute, 2000
- Phase II Trial of Intraperitoneal Cisplatin and Mitoxantrone in Patients with Persistent Ovarian CancerGynecologic Oncology, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- A Phase II Trial of Intraperitoneal Cisplatin and Etoposide as Consolidation Therapy in Patients with Stage II–IV Epithelial Ovarian Cancer Following Negative Surgical AssessmentGynecologic Oncology, 1998
- Five-Year Survival after Second-Line Cisplatin-Based Intraperitoneal Chemotherapy for Advanced Ovarian CancerGynecologic Oncology, 1998
- Pharmacokinetic Problems in Peritoneal Drug Administration: Tissue Penetration and Surface ExposureJNCI: Journal of the National Cancer Institute, 1997
- Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian CancerNew England Journal of Medicine, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Intraperitoneal chemotherapy: Analysis of complications with an implanted subcutaneous port and catheter systemGynecologic Oncology, 1991
- Pharmacology of Intraperitoneal ChemotherapyCancer Investigation, 1983